Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 70/100

BD to Announce Financial Results for its First Quarter of Fiscal 2023 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results...

Key Takeaway: Becton, Dickinson and Company (BD) will announce its financial results for the first quarter of fiscal year 2023 on February 2, 2023. The company will provide a news release and host an audio webcast to discuss the results and updates on operations. BD, a leader in global medical technology, focuses on improving health through innovative solutions. The webcast will be accessible via their investor relations website, which will also host a replay after the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is set to report its financial results, indicating ongoing operations.
  • The company continues to innovate in medical technology, contributing to healthcare advancements.
  • Management is proactively communicating with investors through webcasts.

Full Press Release Details

FRANKLIN LAKES, N.J. , Jan. 5, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2023 on Thursday, February 2, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation materials. The news release and presentation materials will include summary financial information for the company's first quarter of fiscal year 2023, which ended on Saturday, December 31, 2022.
BD management will host an audio webcast at 8 a.m. ET on February 2 , 2023 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .
Contacts:
Media : Investors :
Troy Kirkpatrick Francesca DeMartino
VP, Public Relations SVP, Head of Investor Relations
858.617.2361 201.847.5743
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will BD report its Q1 fiscal year 2023 results?

BD will report its Q1 fiscal year 2023 results on February 2, 2023.

What time will the audio webcast take place?

The audio webcast will occur at 8 a.m. ET on February 2, 2023.

Where can I find BD's financial results and presentation materials?

BD's financial results and presentation materials will be available at www.bd.com/investors.

What is BD's focus in the health care sector?

BD focuses on improving medical discovery, diagnostics, and care delivery.

How many employees does BD have?

BD has approximately 77,000 employees working globally.

Last updated: Jan 5, 2023